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Abstract
Background: Dietary supplementation of zinc oxide (ZnO) to 2000 to 4000 mg/kg is known to be effective for the
prevention and treatment of post-weaning diarrhea in the pig. Such a ‘pharmacological’ supplementation, however, can
potentially result in environmental pollution of the heavy metal, because dietary ZnO is mostly excreted unabsorbed. Two
experiments (Exp.) were performed in the present study to determine the effects of a lipid-coated ZnO supplement
Shield Zn (SZ) compared with those of ZnO.
Methods: In Exp. 1, a total of 240 21-day-old weanling pigs were fed a diet supplemented with 100 mg Zn/kg as ZnO
(ZnO-100), ZnO-2500, SZ-100, or SZ-200 in 24 pens for 14 days on a farm with its post-weaning pigs exhibiting a low
incidence of diarrhea. Exp. 2 was performed using 192 24-day-old piglets as in Exp. 1 on a different farm, which exhibited
a high incidence of diarrhea.
Results: In Exp. 1, fecal consistency (diarrhea) score (FCS) was less for the ZnO-2500 and SZ-200 groups than for the SZ-
100 group (P < 0.05), with no difference between the SZ-100 and ZnO-100 groups. Both average daily gain (ADG) and
gain:feed ratio were less for the SZ-200 group than for the ZnO-2500 group, with no difference between the ZnO-100
group and SZ-100 or SZ-200 group. The villus height (VH), crypt depth (CD), and VH:CD ratio of the intestinal mucosa
were not influenced by the treatment. In Exp. 2, FCS was lowest for the ZnO-2500 group, with no difference among the
other groups. However, neither the ADG nor gain:feed ratio was influenced by the treatment.
Conclusion: Results suggest that physiological SZ supplementation has less beneficial effects than pharmacological ZnO
for the alleviation of diarrhea irrespective of its severity and for promoting growth without influencing their integrity of
the intestinal mucosal structures with little advantage over physiological ZnO in weanling pigs with a small pen size.
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Background
Weaning is accompanied by impaired structural integrity
and physiological function of the intestinal villus due to
the abrupt change in diet, which results in transient
diarrhea and growth retardation in weanling pigs [1–3].
Dietary supplementation of zinc oxide (ZnO) to 2000 to
4000 mg/kg is known to be effective for the prevention
and treatment of post-weaning diarrhea [4–6]; therefore,
the first-phase post-weaning pig diet is supplemented
with approximately 3000 mg ZnO/kg in many countries,
including Korea [7, 8]. Such a pharmacological supple-
mentation, however, can potentially result in environ-
mental pollution of the heavy metal, because 75 to 90%
of dietary ZnO is excreted unabsorbed [9, 10]. The EU
therefore limits dietary Zn concentration to 150 mg/kg
or less by legislation [11], which may lead non-European
countries to adopting similar legislation. This has also
* Correspondence: bcpark@snu.ac.kr
†Equal contributors
4Graduate School of International Agricultural Technology, Institute of Green
Bio Science and Technology, Seoul National University, Pyeongchang 25354,
South Korea
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Byun et al. Journal of Animal Science and Technology  (2017) 59:29 
DOI 10.1186/s40781-017-0159-z
called for the manufacture of high-bioactive ZnO addi-
tives that are just as effective at a dosage lower than the
pharmacological ZnO, thereby enabling a reduction of
supplemental Zn concentrations.
Shield Zn® (SZ) is a lipid-coated ZnO product that has
been designed to maximize the delivery of the mineral
particle to the intestine without being ionized in the
stomach due to the lipid coating. The present group has
reported that dietary provision of 72 mg Zn/kg using SZ
was comparable to 2000 mg Zn/kg as ZnO in its effects
on the alleviation of diarrhea and impaired weight gain
and intestinal villus structure in weanling pigs chal-
lenged with enterotoxigenic Escherichia coli (ETEC) K88
[12, 13]. These effects of dietary SZ supplementation,
however, were not consistent in unchallenged piglets in
our previous studies. Supplementation of neither 100 to
250 mg Zn/kg as SZ nor 2500 mg Zn/kg as ZnO had
any effect on the growth performance of the piglets
which were housed in experimental-scale pens with a 4-
animal unit size, as reported by Jang et al. [14]. In larger
pens with a 34-piglet unit size [15], dietary provision of
100 mg Zn/kg as SZ enhanced the rate of weight gain,
albeit to a lesser extent compared to that with 2500 mg
Zn/kg as ZnO, without influencing the intestinal villus
structure. The intestinal villus structure did not change
due to 100 mg Zn/kg provided by SZ or 2500 mg Zn/kg
by ZnO in either study, but an increase in villus height
or the villus height:crypt depth ratio in response to
250 mg Zn/kg vs. 100 mg Zn/kg by SZ was detected in
Jang et al. [14]. These results from the challenged and
unchallenged piglets suggest that the effects of SZ in
weanling pigs may vary depending on the ETEC
infection status, pen size, and supplemented SZ concen-
tration. The present study was therefore performed to
determine the effects of ‘physiological’ dietary SZ
compared with those of pharmacological as well as
physiological ZnO in small pens in two groups of wean-
ling pigs that had exhibited a low incidence and a high
incidence of post-weaning diarrhea, respectively.
Methods
Experiments (Exp.) 1 and 2 described below were
conducted on two commercial swine farms with a
low incidence and a high incidence of post-weaning
diarrhea, respectively.
Exp. 1
A total of 240 21-day-old weanling pigs with equal num-
bers of females and castrated males born to Duroc-sired
Landrace × Yorkshire dams were allotted to twenty-four
1.3 m × 1.5 m pens according to the sex and body weight
(low, medium, or high) under a randomized complete
block design with 6 replicates (pens) per treatment and
10 piglets per pen. The piglets received a dietary
provision of 100 mg Zn/kg as ZnO (ZnO-100), ZnO-
2500, 100 mg Zn/kg as SZ (Shield Zn®; CTCBIO Inc.,
Seoul, Korea) with 10% (w/w) lipid coating (SZ-100), or
SZ-200 supplemented to a basal diet (Table 1) which
was formulated to meet the nutrient composition rec-
ommended by NIAS [16]. The animals were provided ad
libitum with water and one of the four experimental
diets for 14 days.
Body weight was measured on days 0, 7, and 14. Aver-
age daily feed intake (ADFI) during each of days 0 to 7
and days 7 to 14 for each pen was calculated by dividing























Digestible energy (Mcal/kg) 3.50
Crude protein (%) 18.50
Ether extract (%) 4.50
Lysine (%) 1.52
a)Provided per kg: 1500 IU vitamin A, 2000 IU vitamin D3, 65 IU vitamin E,
1.5 mg vitamin K, 1.0 mg thiamin, 6 mg riboflavin, 20 mg pantothenic acid,
25 mg niacin, 1.5 mg vitamin B6, 1 mg folic acid, 25 μg vitamin B12, 25 μg
biotin, and 150 mg choline
b)Provided per kg: 160 mg Cu, 200 mg Fe, 40 mg Mn, 1 mg I, 0.15 mg Co, and
0.4 mg Se
c)Provided per total weight: 0.1% choline-HCl, 0.347% L-lysine-HCl (78%),
0.150% DL-methionine (99%), 0.114% L-threonine (99%), 0.009% L-tryptophan,
and 0.05% ethoxyquin
d)Four experimental diets were supplemented to the basal diet with 125 and
3125 mg ZnO and with 139 and 278 mg of 10% lipid (w/w)-coated ZnO
(Shield Zn®) per kg diet, respectively, as well as with 0 to 0.30% corn, to
provide 100, 2500, 100, and 200 mg Zn/kg, respectively, and also to make
100.00 for the sum of percentages of all ingredients
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the total feed intake by the sum of the numbers of ani-
mals on feed. For the gain:feed ratio, the average daily
gain (ADG) for each pen was calculated, followed by
division of the calculated ADG by ADFI. Fecal
consistency was scored subjectively as previously de-
scribed [14, 15] except that this study used a 0-to-2 scale
instead of the 1-to-3 scale used in the previous studies:
0, normal firm feces; 1, soft feces; and 2, diarrhea.
At the end of the feeding trial, a total of 24 animals
randomly selected from each of the 24 pens were killed
by electric stunning, after which the entire intestinal
tracts were removed and the intestinal specimens were
prepared as previously described [12, 17]. Briefly, a 5-cm
cross-section excised from each of the duodenum,
jejunum, and ileum was rinsed in phosphate buffered
saline, fixed in 10% formalin, embedded in paraffin film,
sliced using the microtome, mounted onto the slide, and
stained with hematoxylin and eosin. The villus height
(VH) and crypt depth (CD) of the intestinal mucosa
were determined microscopically using the Diagnostic
Insight visual analysis program (Olympus Co., Tokyo,
Japan) and the average for each of the VH and CD
measurements at four villi was taken as a replicate as
also described [12, 17].
Exp. 2
A total of 192 (Landrace × Yorkshire) × Duroc piglets
were allotted to twenty-four 1.4 m × 1.5 m pens at
weaning at 24 days of age, with 6 replicates (pens)
per treatment and 4 females and 4 castrated males
per pen. The animals were subjected to the same
14-day feeding trial as in Exp.1, including the scoring
of fecal consistency and the measurement and calcu-
lation of growth performance, but histological exam-
ination was not included for Exp. 2.
Statistical analysis
Data were analyzed as a randomized complete block de-
sign using the General Linear Model procedure of SAS
(SAS Inst. Inc., Cary, NC, USA) for all the variables in
Exp. 1 and for all variables except the ADFI and gain:-
feed ratio in Exp. 2. The pen, which was the experimen-
tal unit for both Exp. 1 and 2, was used as the error
term to test the effect of the treatment. In the analysis of
the fecal consistency score (FCS), the effects of the day
and the day × treatment interaction were tested using
the day × pen as the error term. The means were sepa-
rated by t test at the 5% significance level.
Results
Exp. 1
The FCS on day 0, which was almost zero indicating
normal firm feces, did not differ among the experimental
groups (Table 2). The FCS increased (P < 0.05) between
days 0 and 7 and returned to day 0 levels at the end of
the experiment on day 14 for all groups except ZnO-
2500, which remained at day 0 levels on days 7 and 14.
The FCS on day 7 was less for the ZnO-2500 group than
for the ZnO-100 and SZ-100 groups as well as for the
SZ-200 group vs. the SZ-100 group. Overall, the mean
FCS was less for the ZnO-2500 and SZ-200 groups than
for the SZ-100 group, and no difference was seen be-
tween the ZnO-100 and SZ-100 groups or between the
ZnO-2500 and SZ-200 groups.
The ADG during the first 7 days was smallest for the
SZ-200 group and was not different among the rest of
the experimental groups. The ADG during the second
7 days was less for the SZ-200 group than for the ZnO-
2500 group, with no difference among the SZ-100 and
-200 and ZnO-100 groups. Overall, ADG for the entire
Table 2 Effects of dietary supplementation of the lipid-coated
ZnO Shield Zn® (SZ) vs. ZnO on fecal consistency and growth
performance in weanling pigs (Exp. 1)
Item ZnO (mg Zn/kg) SZ (mg Zn/kg) SEM P value
100 2500 100 200
FCS1),2)
Day 0 0.07y 0.03 0.03y 0.00y
Day 7 0.52b,x 0.25c 0.93a,x 0.43bc,x 0.083)
Day 14 0.24y 0.07 0.21y 0.15y
Overall4) 0.28ab 0.12c 0.39a 0.19bc 0.04 0.002
Body weight1) (kg)
Day 0 6.10 6.36 6.30 6.45 0.11 0.197
Day 7 7.70 7.87 7.76 7.69 0.12 0.712
Day 14 8.92b 9.70a 9.27ab 8.70b 0.22 0.043
ADG1) (g)
Days 0 to 7 229a 216a 207a 176b 9 0.009
Days 7 to 14 165b 262a 218ab 150b 22 0.013
Overall 197bc 241a 212ab 155c 14 0.011
ADFI5) (g)
Days 0 to 7 261 257 253 249 8 0.792
Days 7 to 14 372 456 387 355 28 0.122
Overall 316 357 320 302 17 0.201
Gain:feed5)
Days 0 to 7 0.88 0.84 0.82 0.76 0.03 0.062
Days 7 to 14 0.43c 0.58a 0.55ab 0.44bc 0.03 0.015
Overall 0.62bc 0.68a 0.66ab 0.56c 0.02 0.010
Exp. experiment, SEM standard error of mean, FCS fecal consistency score, ADG
average daily gain, ADFI average daily feed intake
a-cMeans with no common superscript within a row differ (P < 0.05)
x,yMeans with no common superscript within a column differ (P < 0.05)
1)Data are least squares means of 6 pens, with 10 piglets per pen
2)Scored subjectively: 0, normal firm feces; 1, soft feces; 2, diarrhea
3)Applies to all day × treatment combinations
4)The P values for the day and day × treatment were <0.001 and
0.009, respectively
5)Data are least squares means of 6 pens
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14 days was greater for the ZnO-2500 group than for
the SZ-200 and ZnO-100 groups as well as for the SZ-
100 group vs. SZ-200, not being different between the
SZ-100 group and either of the two ZnO groups.
The ADFI was not affected by the treatment during
the period of days 0–7, 7–14, or 0–14. The gain:feed ra-
tio was not influenced by the treatment during the first
7-day period. The gain:feed ratio during the second 7-
day period was greater for the ZnO-2500 and SZ-100
groups than for the ZnO-100 group. Furthermore, the
gain:feed ratio for entire 14-day period was greater for
the ZnO-2500 and SZ-100 groups vs. SZ-200 group,
with no difference between the SZ-100 group and either
of the ZnO-100 and ZnO-2500 groups.
None of the effects of the treatment on VH, CD, and
VH:CD ratio in the duodenum, jejunum, and ileum was
significant (P > 0.05; Table 3).
Exp. 2
The FCS increased between days 0 and 7 and decreased
between days 7 and 14 as in Exp. 1 (Table 4). The FCS
on day 14 was an intermediate value between those on
days 0 and 7 in the ZnO-100 and SZ-100 groups
whereas it did not differ from that on day 0 in the ZnO-
2500 and SZ-200 groups. The mean FCS was greater for
the SZ-100 and SZ-200 groups than for the ZnO-2500
group, but was not different between the ZnO-100
group and either of the two SZ groups or between the
SZ-200 and SZ-100 groups.
The ADG during the first 7 days was less for the SZ-
100 and -200 groups than for the ZnO-2500 groups.
However, the treatment effects on ADG during the
second 7 days and for the entire 14 days were not
significant.
The ADFI did not differ among the treatments during
any experimental period. The gain:feed ratio during days
0–7 was less for the SZ-100 and SZ-200 groups than for
the ZnO-2500 group; however, the gain:feed ratio was
not influenced by the treatment during the period of
days 7–14 or 0–14.
When the data from Exp. 1 and Exp. 2 were pooled,
the FCS was greater for Exp. 2 than for Exp. 1 (0.24 vs.
0.45; SEM = 0.03; P < 0.01) as expected. Moreover, the
ADG and gain:feed ratio during the first 7 days were
greater (P < 0.01) for Exp. 1 (206 ± 7 g and 0.82 ± 0.06,
respectively) than for Exp. 2 (92 ± 7 g and 0.47 ± 0.06, re-
spectively). During the second 7 days, however, both
ADG and gain:feed ratio were greater (P < 0.01) for Exp.
Table 3 Effects of dietary supplementation of the lipid-coated
ZnO Shield Zn® (SZ) vs. ZnO on intestinal mucosal morphology
of weanling pigs (Exp. 1)
Item ZnO (mg Zn/kg) SZ (mg Zn/kg) SEM P value
100 2500 100 200
Duodenuma)
VH (μm) 290 293 271 244 19 0.260
CD (μm) 216 236 208 226 13 0.504
VH:CD ratio 1.35 1.27 1.34 1.07 0.11 0.261
Jejunuma)
VH (μm) 297 280 276 245 16 0.187
CD (μm) 209 234 206 205 12 0.685
VH:CD ratio 1.43 1.28 1.37 1.22 0.11 0.540
Ileuma)
VH (μm) 234 223 257 224 10 0.089
CD(μm) 171 182 176 181 14 0.947
VH:CD ratio 1.39 1.27 1.48 1.28 0.08 0.223
Exp. experiment, SEM standard error of mean, VH villus height, CD crypt depth
a)Data are means of 6 pens, with one animal analyzed per pen
Table 4 Effects of dietary supplementation of the lipid-coated
ZnO Shield Zn® (SZ) vs. ZnO on fecal consistency and growth
performance of weanling pigs (Exp. 2)
Item ZnO (mg Zn/kg) SZ (mg Zn/kg) SEM P value
100 2500 100 200
FCS1),2)
Day 0 0.11z 0.02y 0.04z 0.23y
Day 7 0.84ab,x 0.63b,x 1.02a,x 0.84ab,x 0.103)
Day 14 0.50y 0.29y 0.36y 0.52y
Overall4) 0.47a 0.31b 0.47a 0.53a 0.05 0.035
Body weight1) (kg)
Day 0 6.86 6.82 6.70 6.81 0.15 0.899
Day 7 7.56 7.67 7.15 7.17 0.15 0.056
Day 14 9.41 9.89 9.18 9.26 0.24 0.189
ADG1) (g)
Days 0 to 7 103ab 131a 63b 60b 18 0.035
Days 7 to 14 257 317 282 274 16 0.097
Overall 180 220 174 168 14 0.065
ADFI5) (g)
Days 0 to 7 182 171 154 154 10 0.203
Days 7 to 14 313 327 361 312 18 0.242
Overall 247 249 253 230 11 0.503
Gain:feed5)
Days 0 to 7 0.54ab 0.71a 0.36b 0.27b 0.10 0.037
Days 7 to 14 0.90 1.00 0.80 0.91 0.06 0.180
Overall 0.76 0.88 0.70 0.77 0.06 0.185
Exp. experiment, SEM standard error of mean, FCS fecal consistency score, ADG
average daily gain, ADFI average daily feed intake
a,bMeans with no common superscript within a row differ (P < 0.05)
x-zMeans with no common superscript within a column differ (P < 0.05)
1)Data are least squares means of 6 pens, with 8 piglets per pen
2)Scored subjectively: 0, normal firm feces; 1, soft feces; 2, diarrhea
3)Applies to all day × treatment combinations
4)The P values for the day and day × treatment were <0.001 and
0.447, respectively
5)Data are least squares means of 6 pens
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2 (283 ± 9 g and 0.90 ± 0.04, respectively) vs. Exp. 1 (200
± 8 g and 0.48 ± 0.04, respectively).
Discussion
The FCS was visibly greater in Exp. 2 than in Exp. 1,
as was expected, indicating a greater severity of post-
weaning pig diarrhea in the former. Moreover, FCS of
the weanling pigs was lower due to the ZnO-2500
treatment vs. ZnO-100 for both Exp. 1 and 2, match-
ing published results from previous studies [4, 18]
including Park et al. [15], whose feeding trial was per-
formed at the same farm where Exp. 1 was
performed. In addition, the lack of effect on FCS for
SZ-100 vs. ZnO-100 was also consistent with our pre-
vious results with commercial piglets [15].
The lesser FCS in response to SZ-200 vs. SZ-100 only
in Exp. 1 suggests that the dose-response effect of SZ on
FCS may depend on the severity of post-weaning diar-
rhea, yet further studies are necessary to confirm this
possibility. With respect to the dose effect of the lipid-
coated ZnO, Shen et al. [19] have reported that FCS of
the post-weaning pigs was lowered by dietary supple-
mentation with 380 or 570 mg Zn/kg, but not with a
lower or higher concentration up to 1140 mg Zn/kg,
provided by a lipid-coated ZnO product compared to
that with 250 mg Zn/kg provided by ZnO. In Wang et
al. [20], post-weaning pig diarrhea was alleviated by
provision of 1500 mg Zn/kg with another lipid-coated
ZnO product to the same extent elicited by 3000 mg
Zn/kg as ZnO, but the dose effects for the former were
not examined in this study. These results, however, can-
not be directly compared with those of the present
study, because how the ZnO particle was coated and
consequently what percentage of the mineral particle
was bio-available in the intestine are unknown for each
of the lipid-coated ZnO products.
It was noteworthy that the ADG and gain:feed ratio
during days 0–7 were much less in Exp. 2 than in Exp.
1, but these performance variables during days 7–14
were much greater in Exp. 2. This suggests that the
growth of the piglets was dampened due to the high se-
verity of post-weaning diarrhea during the first week in
Exp. 2, whereas a compensatory growth occurred during
the second week with the decreased severity of diarrhea
between days 7 and 14. Regarding the effects of the
treatment on performance, the greater ADG and greater
gain:feed ratio for the ZnO-2500 treatment vs. ZnO-100
in Exp. 1 were consistent with the known growth-
promoting effect of pharmacological ZnO published in
the literature [4, 21] including the report of our own
[15]. However, the lack of effect on ADG for the SZ-100
treatment vs. ZnO-100 in both Exp. 1 and 2 was incon-
sistent with the low, but significant growth-enhancing
effect for the former observed in the previous study [15],
and the dose effects of SZ on the ADG and gain:feed ra-
tio were not consistent between Exp. 1 and 2.
The VH and VH:CD ratio are commonly used as posi-
tive indices for estimating the integrity of the intestinal
mucosal structure, whereas CD is regarded as a negative
index [6, 22]. The VH and VH:CD ratio do not change
consistently in response to pharmacological ZnO, being
increased [23], unchanged [24], or even decreased [25]
by the dietary ZnO treatment. Reasons for this inconsist-
ent response of the piglets to dietary ZnO are not clearly
known, but are apparently associated with the diarrhea-
reducing effect and antimicrobial properties of ZnO [6,
26, 27]. In this context, amelioration of impaired intes-
tinal villus structure caused by an ETEC K88 challenge
by the ZnO or SZ treatment in weanling pigs was associ-
ated with reduced intestinal adhesion and fecal shedding
of the challenged pathogen accompanied by reduced
FCS in our previous studies [12, 13]. By analogy, the lack
of effects of either ZnO-2500 or SZ treatment on the
structural variables in the present study was probably
because the presumptively impaired intestinal villus
structure due to weaning recovered to a normal state
after several days post-weaning, which was extrapolated
from the transient increase and subsequent decrease of
FCS by day 14 when the intestinal tissues were sampled.
Conclusions
The results of the present study indicated that pharmaco-
logical ZnO, but not physiological SZ, was effective for the
alleviation of diarrhea irrespective of its severity and for
promoting growth without influencing their integrity of
the intestinal mucosal structures in post-weaning pigs
when they were housed in small unit-size pens of 10 ani-
mals or less. However, relative effects for the SZ-100 and
SZ-200 treatments on post-weaning diarrhea and growth
performance were inconclusive. Obviously, more studies
are necessary to determine the comprehensive dose-
response effects for SZ, because only two doses of SZ were
included in the present study to examine the relative ef-
fects of SZ near the upper limit of the in-feed Zn concen-
tration of the EU (150 mg/kg [11]).
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